Document is current
Any future updates will be listed below
-
Authors
Antinew, Jeremias
Fountaine, Robert J.
Loprinzo, Vittorio
Straghan, Esther
Dubrovin, Sergey
DeBesi, Patrizia
Vatakis, Nick
Fullerton, Terence
- License Information
-
More Information
Article History
Received: 8 September 2025
Accepted: 16 November 2025
First Online: 9 December 2025
Declarations
:
: The study protocol was approved by the Advarra Institutional review Board (Columbia, MD). All participants provided written informed consent.
: Not applicable
: JA, RJF, VL, ES, SD, PD, and TF are (or were at the time of the study) employees of, and own stock/options in, Pfizer. NV has no competing interests to disclose.
